Marijuana Moment

Trump’s Marijuana Rescheduling Order Could Include Industry Banking And CBD Medicare Coverage Provisions, Sources Say

Cannabis industry observers believe it is increasingly likely that President Donald Trump will soon sign an executive order ...

Donald Trump Scores Big Win on Medicare, Medicaid Drug Pricing

The deal adds some of the biggest names in drug manufacturing to the president's "most favored nation" pricing plan.
The Daily Overview on MSN

Trump lands major win on Medicare and Medicaid drug pricing

President Donald Trump has secured a sweeping set of drug pricing concessions that reach deep into both Medicare and Medicaid, reshaping how some of the most expensive medicines will be paid for in ...
Marijuana Moment

Trump’s Marijuana Executive Order Details Leaked Ahead Of Announcement, Including CBD And Hemp Provisions

President Donald Trump will be signing an executive order on Thursday that will direct the attorney to “expedite” and “complete” the marijuana rescheduling process, throw a lifeline to the hemp ...
Lawrence Journal-World

Trump signs executive order to reclassify marijuana as less dangerous drug; KBI makes point to warn of its dangers and illegality

President Donald Trump signed an executive order Thursday that could reclassify marijuana as a less dangerous drug and open ...

Trump, nine pharmaceutical companies strike deal to cut drug prices

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

President Trump Signs Executive Order To Reschedule Cannabis As Less Dangerous Drug

The move to Schedule III marks the greatest change to U.S. drug laws since 1970 and represents a new future for the $32 ...

COMMENTARY: The real story behind Trump’s GLP-1 price cut: Markets still rule

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...

Trump touts deal with 9 drug companies that will reduce prescription prices

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

Trump moves to ban transgender care for minors by targeting hospitals

US Health and Human Services Secretary Robert F. Kennedy Jr. and other health officials said Thursday that the federal government will block hospitals and doctors from providing transgender care to ...